Intellectual Property India Publishes Patent Application for Prophylactic Or Therapeutic Agent For Pulmonary Hypertension, And Method For Examining Presence Or Absence Of Pulmonary Hypertension Or Severity Of Pulmonary Hypertension

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617074948 A) filed by National Cerebral And Cardiovascular Center on June 17, 2026, for Prophylactic Or Therapeutic Agent For Pulmonary Hypertension, And Method For Examining Presence Or Absence Of Pulmonary Hypertension Or Severity Of Pulmonary Hypertension.

Inventors include Nakaoka, Yoshikazu; Okazawa, Makoto; and Asano, Ryotaro.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: The problem addressed by the present disclosure is to provide a prophylactic or therapeutic agent for pulmonary hypertension. A prophylactic or therapeutic agent for pulmonary hypertension according to the present disclosure contains a substance that adsorbs or binds to an indole compound that is a tryptophan metabolite.

Disclaimer: Curated by HT Syndication.